Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Meteospasmyl® in Irritable Bowel Syndrome. a 4-Week, Multicentre, Double-Blind, Randomised, Placebo-Controlled Phase IV Trial

NCT00542295 is registered in ClinicalTrials.gov with Laboratoires Mayoly Spindler as lead sponsor.

NCT NCT00542295
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00542295 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Meteospasmyl® in Irritable Bowel Syndrome. a 4-Week, Multicentre, Double-Blind, Randomised, Placebo-Controlled Phase IV Trial
Lead sponsor
Laboratoires Mayoly Spindler
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2007
Completion date
September 30, 2008
Enrollment
400 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel syndrome